{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:41:09Z","timestamp":1740807669274,"version":"3.38.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.remnie.2025.500071","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T17:23:48Z","timestamp":1737221028000},"page":"500071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of a negative [18F]F-PSMA PET\/CT study in patients diagnosed with prostate cancer treated with prostatectomy with PSA rising below 1\u202fng\/mL after radical prostatectomy, on the outcome of salvage radiotherapy"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"C\u00f3zar Santiago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garc\u00eda Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Esteban Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pastor Peiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ferrer Rebolleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.remnie.2025.500071_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remnie.2025.500071_bib0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12094-021-02561-5","article-title":"SEOM clinical guidelines for the treatment of advanced prostate","volume":"23","author":"Gonzalez del Alba","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.remnie.2025.500071_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, Diagnosis and Local Treatment with Curative Intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.remnie.2025.500071_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version2.2019. NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.remnie.2025.500071_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","article-title":"Available evidence on HIFU for focal treatment of prostate cancer: a systematic review","volume":"48","author":"Bakavicius","year":"2022","journal-title":"Int Braz J Urol."},{"key":"10.1016\/j.remnie.2025.500071_bib0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.remnie.2025.500071_bib0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euo.2023.01.014","article-title":"Metastatic sites\u2019 location and impact on patient management after the introduction of prostate-specific membrane antigen positron emission tomography in newly diagnosed and biochemically recurrent prostate cancer: a critical review","volume":"6","author":"Mattana","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.remnie.2025.500071_bib0050","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500071_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2019.01.045","article-title":"Androgen deprivation therapy and salvage radiotherapy: are we missing something?","volume":"76","author":"Gonz\u00e1lez-San Segundo","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JU.0000000000002759","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline 2022","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JU.0000000000001369","article-title":"Detection rate of prostate specific membrane antigen tracersfor positron emission tomography \/ computerized tomography in prostate cancer biochemical recurrence: a systematic review and network meta-analysis","volume":"205","author":"Crocerossa","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.13540","article-title":"Prospective evaluation of 68gallium-prostatespecific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer","volume":"119","author":"Van Leeuwen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.remnie.2025.500071_bib0075","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of 68gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2025.500071_bib0080","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1007\/s00330-016-4308-4","article-title":"68Ga-PSMA I&T PET\/CT for assessment of prostate c\u00e1ncer: evaluation of image quality after forced diuresis and delayed imaging","author":"Derlin","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.remnie.2025.500071_bib0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2967\/jnumed.116.183483","article-title":"The clinical impact of additional","volume":"58","author":"Afshar-Oromieh","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500071_bib0090","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","article-title":"Treatment outcomes from 68Ga-PSMA PET\/CT\u2013informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET","volume":"58","author":"Emmett","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500071_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2967\/jnumed.117.201749","article-title":"68 Ga-PSMA-11 PET\/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng\/mL: impact on salvage radiotherapy planning","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500071_bib0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2967\/jnumed.117.196444","article-title":"The utility of PET\/CT in the planning of external radiation","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.remnie.2025.500071_bib0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14748","article-title":"Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET\u2013based salvage radiotherapy for recurrent prostate cancer","volume":"6","author":"Zamboglou","year":"2023","journal-title":"JAMA Network Open."},{"key":"10.1016\/j.remnie.2025.500071_bib0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.euf.2020.12.009","article-title":"Update from PSMA-SRT Trial NCT03582774: a randomized phase 3 imaging trial of prostate-specific membrane antigen positron emission tomography for salvage radiation therapy for prostate cancer recurrence powered for clinical outcome","volume":"7","author":"Calais","year":"2021","journal-title":"Eur Urol Focus"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:28:00Z","timestamp":1740760080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2253808925000102"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500071","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of a negative [18F]F-PSMA PET\/CT study in patients diagnosed with prostate cancer treated with prostatectomy with PSA rising below 1\u202fng\/mL after radical prostatectomy, on the outcome of salvage radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2024.500071","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500071"}}